Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Tradipitant demonstrates antipruritic effect in mild atopic dermatitis in phase III EPIONE study

Feb. 26, 2020

Novan gives update on the phase III B-SIMPLE program of SB-206

Feb. 7, 2020

New Trk-A, Trk-B and Trk-C inhibitors discovered at BenevolentAI Bio

Feb. 6, 2020

Aurigene initiates phase II study of AUR-101 in moderate to severe psoriasis

Feb. 4, 2020

German Medicines Agency approves phase II study of FOL-005

Jan. 31, 2020

BREEZE-AD5 phase II study of baricitinib in AD meets primary endpoint

Jan. 31, 2020

MicroCures advances burn wound healing collaborative research project

Jan. 30, 2020

TRuE-AD2 pivotal phase III study of ruxolitinib cream meets primary endpoint

Jan. 29, 2020

Daiichi Sankyo begins phase I study in Japan with DS-2741a for atopic dermatitis

Jan. 27, 2020

Phase III BREEZE-AD4 trial of baricitinib in atopic dermatitis meets primary endpoint

Jan. 27, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...